Nicolas Marcoux

1.2k citations
12 papers · 916 · 1 hit paper · h-index 9

Impact in

  • Oncology top 5%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Research Studies 3
    • Cancer Immunotherapy and Biomarkers 2
    • Colorectal Cancer Treatments and Studies 2
    • CAR-T cell therapy research 1
    • Lung Cancer Treatments and Mutations 5
    • Sarcoma Diagnosis and Treatment 1

Nicolas Marcoux

11 papers receiving 908 citations

Nicolas Marcoux's Hit Papers

Landscape of Acquired Resistance to Osimertinib in EGFR -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion 2018 · 371 citations
3710+2+5Years since publication100200300

Peers

Nicolas Marcoux
Comparison fields: 5 of 40
  • Oncology 500
  • Pulmonary and Respiratory Medicine 585
  • Cancer Research 170
  • Molecular Biology 270
  • Pathology and Forensic Medicine 53
Replace Jacinta Wiens with:
Jacinta Wiens United States
Yoshitaka Zenke Japan
Yoshiro Fujiwara Japan
Pil Gyu Hwang South Korea
Reiko Kaji Japan
Yunzhong Zhu China
S.‐H.I. Ou United States
Ilze Bāra United States
Hideko Isozaki Japan
Felip Cardenal Spain
Nicolas Marcoux relative to Jacinta Wiens United States Jacinta Wiens's profile →
Citations per field
00.5×2×4×6.6×
Jacinta Wiens · 1×
Citations per year

Countries citing papers authored by Nicolas Marcoux

Since Specialization
Citations

This map shows the geographic impact of Nicolas Marcoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Marcoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Marcoux more than expected).

Fields of papers citing papers by Nicolas Marcoux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Marcoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Marcoux. The network helps show where Nicolas Marcoux may publish in the future.

Co-authors

The 25 scholars most cited alongside Nicolas Marcoux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicolas Marcoux Line = papers co-authored together Nicolas Marcoux links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 2018392
2
Landscape of Acquired Resistance to Osimertinib in EGFR -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion
Hit paper breakdown →
2018371
3 202064
4 202421
5 202619
6 202417
7 201710
8 202310
9 20179
10 20242
11 20171
12 20250

About Nicolas Marcoux

Nicolas Marcoux is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 12 papers that have together received 916 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Sarcoma Diagnosis and Treatment (1 paper), RNA modifications and cancer (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (500 citations), Pulmonary and Respiratory Medicine (585 citations), Cancer Research (170 citations), Molecular Biology (270 citations) and Pathology and Forensic Medicine (53 citations). Nicolas Marcoux has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Rebecca J. Nagy, Richard Burnham Lanman, Zofia Piotrowska, Lecia Van Dam Sequist, Saman Maleki Vareki, Anna F. Farago, Scott N. Gettinger, Anthony John Iafrate, Dora C. Dias-Santagata and Jonathan Christopher Noujaim. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Discovery, Nature Medicine and Cancer Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact